Regeneron Pharmaceuticals Inc Cash Flow Quality Index
Regeneron Pharmaceuticals Inc cash flow quality index. Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Quality Index of 0.44x as of June 2026. Operating cash flow of $574.50 Million is below net income of $1.30 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Regeneron Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Regeneron Pharmaceuticals Inc (2004–2025)
Cash flow quality index of Regeneron Pharmaceuticals Inc from 2004 to 2025. Historical Cash Flow Quality Index for Regeneron Pharmaceuticals Inc across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Regeneron Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Regeneron Pharmaceuticals Inc Cash Flow Quality Index by Year (2004–2025)
Regeneron Pharmaceuticals Inc cash flow quality index by year from 2004 to 2025. Year-by-year earnings quality comparison for Regeneron Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Regeneron Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | $4.98 Billion | $4.50 Billion | ▲ +10.3% |
| 2024 | 1.00x | $4.42 Billion | $4.41 Billion | ▼ -13.8% |
| 2023 | 1.16x | $4.59 Billion | $3.95 Billion | ▲ +0.5% |
| 2022 | 1.16x | $5.01 Billion | $4.34 Billion | ▲ +31.8% |
| 2021 | 0.88x | $7.08 Billion | $8.08 Billion | ▲ +17.7% |
| 2020 | 0.75x | $2.62 Billion | $3.51 Billion | ▼ -35.1% |
| 2019 | 1.15x | $2.43 Billion | $2.12 Billion | ▲ +27.9% |
| 2018 | 0.90x | $2.20 Billion | $2.44 Billion | ▼ -17.7% |
| 2017 | 1.09x | $1.31 Billion | $1.20 Billion | ▼ -34.3% |
| 2016 | 1.66x | $1.49 Billion | $895.52 Million | ▼ -20.7% |
| 2015 | 2.09x | $1.33 Billion | $636.06 Million | ▼ -3.2% |
| 2014 | 2.16x | $752.43 Million | $348.07 Million | ▲ +55.9% |
| 2013 | 1.39x | $588.60 Million | $424.36 Million | ▲ +1494.7% |
| 2012 | -0.10x | $-74.61 Million | $750.27 Million | ▲ +75.5% |
| 2004 | -0.41x | $-16.91 Million | $41.70 Million | — |